$DWTX 4 SEC Filings

Filed On	Filing
27 Oct 2026	Form 4: Sealbond Ltd, Director and 2 others Received 4,098,360 shares as a grant or award ($5M)
17 Jun 2026	Form 4: De La Rosa Abel, Director Granted 16,800 Stock Option (right to buy)
17 Jun 2026	Form 4: Thomas John C, Director Granted 16,800 Stock Option (right to buy)
17 Jun 2026	Form 4: Whitley Richard James, Director Granted 16,800 Stock Option (right to buy)
17 Jun 2026	Form 4: Keefer David R, Director Granted 16,800 Stock Option (right to buy)
06 Mar 2026	Form 4: Grosswald Ralph, SVP OF OPERATIONS Granted 82,500 Stock Option (right to buy)
06 Mar 2026	Form 4: Walsh Angela, Chief Financial Officer Granted 82,500 Stock Option (right to buy)
06 Mar 2026	Form 4: Gendreau Roger Michael, CHIEF MEDICAL OFFICER Granted 82,500 Stock Option (right to buy)
06 Mar 2026	Form 4: Duncan Gregory Scott, Director Granted 330,000 Stock Option (right to buy)
05 Dec 2025	Form 4: Duncan Gregory Scott, Director Granted 460,000 Stock Option (right to buy)
05 Dec 2025	Form 4: Grosswald Ralph, SVP OF OPERATIONS Granted 150,000 Stock Option (right to buy)
05 Dec 2025	Form 4: Gendreau Roger Michael, CHIEF MEDICAL OFFICER Granted 150,000 Stock Option (right to buy)
05 Dec 2025	Form 4: Walsh Angela, Chief Financial Officer Granted 150,000 Stock Option (right to buy)
25 Nov 2025	Form 4: Sealbond Ltd, Director and 2 others Received 24,453,588 shares by conversion
01 Jul 2025	Form 4: Gendreau Roger Michael, CHIEF MEDICAL OFFICER Granted 12,075 Stock Option (right to buy)
01 Jul 2025	Form 4: Whitley Richard James, Director Granted 2,362 Stock Option (right to buy)
01 Jul 2025	Form 4: Grosswald Ralph, SVP OF OPERATIONS Granted 12,075 Stock Option (right to buy)
01 Jul 2025	Form 4: Thomas John C, Director Granted 2,362 Stock Option (right to buy)
01 Jul 2025	Form 4: Duncan Gregory Scott, Director Granted 40,000 Stock Option (right to buy)
01 Jul 2025	Form 4: Keefer David R, Director Granted 2,362 Stock Option (right to buy)

Comments